X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2023-25079.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.expresspharma.in/health-canada-approves-ryaltris-for-treatment-of-seasonal-allergic-rhinitis/
https://www.pharmaceutical-technology.com/news/health-canada-glenmark-allergic-rhinitis/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmarks-partner-hikma-launches-specialty-drug-ryaltris-in-us/articleshow/93884151.cms
https://www.prnewswire.com/news-releases/hikma-launches-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us-301614600.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf
https://www.aninews.in/news/world/europe/glenmark-receives-marketing-approval-for-ryaltris-in-13-countries-across-eu-uk20210930110052/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-arm-gets-russian-health-ministry-nod-for-nasal-spray-ryaltris/articleshow/81147882.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213514
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-laboratories-launches-over-the-counter-eye-allergy-drop-in-us/articleshow/78162091.cms
https://www.prnewswire.com/news-releases/hikma-and-glenmark-pharmaceuticals-enter-into-exclusive-licensing-agreement-for-commercialising-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us-301012213.html
https://www.raps.org/news-and-articles/news-articles/2020/2/rx-to-otc-switches-fda-signs-off-on-three-drugs
https://www.fda.gov/news-events/press-announcements/fda-approves-three-drugs-nonprescription-use-through-rx-otc-switch-process
https://www.business-standard.com/article/pti-stories/glenmark-gets-approval-from-australian-regulator-to-commercialise-ryaltris-119122000275_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209752
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209826
https://www.fiercepharma.com/manufacturing/glenmark-respiratory-drug-has-wind-knocked-out-it-by-fda-questions-production
https://health.economictimes.indiatimes.com/news/pharma/alembic-pharmaceuticals-gets-usfda-nod-for-ophthalmic-solution/68004578
https://www.biospectrumindia.com/news/57/12745/glenmark-pharma-signs-an-agreement-with-grandpharma-.html
http://www.glenmarkpharma.com/sites/default/files/Glenmark-Pharma-enters-into-an-Exclusive-Licensing-Agreement-with-Yuhan-Corporation-for-commercializing-Investigational-Seasonal-Allergic-Rhinitis-Nasal-Spray-Ryaltris.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209015
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209919
https://health.economictimes.indiatimes.com/news/pharma/alembic-pharmaceuticals-gets-usfda-nod-for-ophthalmic-solution/67021064
https://www.ftc.gov/news-events/press-releases/2018/07/ftc-approves-final-order-imposing-conditions-merger-generic-drug
https://www.thehindubusinessline.com/companies/glenmarkpharma-arm-inks-pact-with-seqirus/article24354471.ece
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206046
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090918
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200810
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204532
http://www.prnewswire.com/news-releases/argentum-and-alcon-settle-patent-dispute-over-pazeo-300370728.html
https://www.pharmacompass.com/pdf/news/akorn-inc-generic-olopatadine-hydrochloride-approved-in-us-1474959647.pdf
http://www.reuters.com/article/us-novartis-alcon-problems-idUSKCN0UP1EE20160111
http://www.business-standard.com/article/companies/aurobindo-riding-higher-on-new-approvals-115122800083_1.html
http://www.business-standard.com/article/companies/aurobindo-pharma-gets-usfda-nod-for-conjunctivitis-eye-drops-115122200270_1.html
Market Place
Share 
